市場調查報告書
商品編碼
921864

全球醫囑遵從性包裝市場:成長,趨勢,及預測(2020年∼2025年)

Adherence Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

預測期內,全球粘附包裝市場預計將以5.9%的複合年增長率增長。推動該市場增長的因素包括對減少藥物浪費的日益增長的需求以及對醫療保健專業人員指令的高度不遵守。通過使用依從性包裝並提供完整的藥物清單,優勢和給藥指導,可以減少患者的藥物過量或藥物不足,從而在預測期內推動市場增長。

本報告提供全球醫囑遵從性包裝市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,包裝類型·材料·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 需要減少藥物浪費
    • 高服藥指示的不服從率
  • 市場阻礙因素
    • 自動化系統的高昂安裝和維護成本
    • 缺乏醫囑遵從性包裝的相關認識
  • 波特的五力分析

第5章 市場區隔

  • 各包裝形式
    • 帶/門廊
    • 泡殼卡
    • 其他
  • 不同材料
    • 塑膠膜
    • 紙·紙板
    • 其他
  • 各終端用戶
    • 零售藥局
    • 醫院
    • 看護設施
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形印象

  • 企業簡介
    • Accu-Chart Plus Healthcare Systems, Inc.
    • Arxium, Inc.
    • Becton, Dickinson and Company
    • Cardinal Health, Inc.
    • Manrex Limited
    • Mckesson Corporation
    • Medicine-On-Time
    • Omnicell
    • Pearson Medical Technologies LLC
    • TCGRx
    • WestRock Company

第7章 市場機會及今後趨勢

目錄
Product Code: 67618

The adherence packing market is expected to register a CAGR of 5.9% over the forecast period from 2020 to 2025. Blister packaging helps prevent children from accidental medicine consumption. Regarding the incidence of hospitalization, with opioid poisoning among children, the CDC reported that, during 2007-2011, for every 500 adults treated with buprenorphine, one child was hospitalized. Hence, the active transition toward blister packaging by 2012 saw a 65% drop in emergency department visits.

Key Highlights

  • Also, more than 80% of emergency department (ED) visits, in line with medication poisoning among children under the age of 12 years, can be attributed to unsupervised children taking medications independently. Additionally, nearly 10% of ED visits are primarily due to medication errors, as per the National Electronic Injury Surveillance System-Cooperative Adverse Event Surveillance System (NEISS-CADES) project. The reduction of dosing intervals is crucial for patients who develop the need to alleviate the anxiety of anticipated pain between dosing intervals. Therefore, adherence packaging offers dosage reminders for patients and caregivers, thus, reducing the likelihood of underdosing or overdosing.
  • Furthermore, recent developments about the digital capture of dispense events via near field communication (NFC) or radio frequency identification (RFID) are being incorporated into packaging for verification, on similar lines. The unit-dose blisters allow passive, active, and interactive features to combat the opioid epidemic and improve pharmaceutical safety. Passive elements refer to graphic or text reminders and warnings. Dynamic features use electronics for reminders or alarms, in case of a shortened dosing period. Moreover, interactive features enable the patients to respond to prompts from the packaging, in the form of recording of doses and timing, to curb the addictive behavior.
  • The recent event, Pharmapack Europe, 2020, highlighted the importance of digital value-added medicines, increased need for waste management, device development in biologics, and blockchain. It went further to address the role of blister packaging in adherence packaging. However, a study on adherence in people with mental disorders across India suggested that the primary cause of non-compliance is due to the high cost of medicines. Pharmaceutical manufacturers can affect the prices of medicine by delivering safe and effective drugs at lower costs. Although the pharma packaging industry cannot be directly associated with the rising cost of products for the end-users, at an operational level, the capital equipment purchases may assist the costs indirectly.
  • Meanwhile, on the vendor front, Acute Technology, a tech-based medication adherence provider, has been stressing upon the use of Hydra Communications Gateway. This may enable the usage of a smartphone to facilitate the electronic monitoring of dosages. This effectively addresses the problem of a lack of control of the medication supplied through weekly medicine trays. However, pharmaceutical companies taking center stage in the COVID-19 fight, such as Gilead and Eli Lilly, are seeing positive growth on the stock market and a new burst of innovation in the infectious disease landscape as the race for treatment approval for a COVID-19 therapy taking off which expected to boost the adherence packaging market significantly.

Key Market Trends

Multi-Dose Packaging is Expected to Witness Significant Growth

  • The importance of medication adherence and the benefits of synchronizing those medications have led to the development of multi-dose packages. The benefits of multi-dose blister cards include setting up dosage time to eliminate confusion, more natural self-medication, and cutting down the number of visits to the pharmacy per month. Multiple studies have proven improved adherence and health outcomes, combined with multimed blister packs and medication therapy management (MTM).
  • A survey conducted by Omnicell suggested that patients assigned to the multimed packaging groups accounted for medication adherence rates of 80% initially, and they even accounted for 90% adherence rates by the completion of the trial. Alternatively, patients assigned to the pill bottle-only group accounted for an adherence rate of 56%. Omnicell offered multimed blister cards to Holyoke Health Center. The health center used Omnicell's SureMed+, a seven-day, four-time pass, cold-seal, bi-fold card.
  • In early 2019, Buffalo Pharmacies offered multimed blister card packaging to patients, caregivers, and pharmacists, for the smooth management of complex medication regimens. To increase patient adherence to medications, the company selected the SureMed packaging system from Omnicell. The system provided perforated cards to offer a level of convenience for the patients. And, the ability to 'tear-off' a dose for on-the-go consumption served as a significant advantage, in terms of adherence packaging.
  • Furthermore, e-commerce players are observed to have been expanding convenience, compliance, and customized healthcare packaging for the elderly population. Last year's Amazon's purchase of the online pharmacy, PillPack, suggests the need for the online delivery of medication, thus, indicating the potential for multimed packs to be demanded. The multi-dose packaging, amid the COVID-19 outbreak, has to ensure a reduced amount of 'touchpoints' for the processing of a patient's prescriptions, while avoiding confusion associated with self-medicating.

North America Dominates the Market and Expected to do Same in the Forecast Period

  • The North American region is developed with prosperous economies, aging population segments, and advanced medical delivery systems. Still, the countries vary measurably in population size, healthcare spending intensities, aggregate gross domestic product (GDP) levels, and the structure of health insurance plans. With advanced primary medical community, extensive medical and life science research activities, high healthcare spending intensity, and large pharmaceutical and medical supply and device industries, the United States accounts for one of the world's largest geographical markets for adherence packaging products.
  • In August 2019, the Healthcare Compliance Packaging Council (HCPC) supported the US Congress' and the FDA's plan to enhance packaging development to reduce opioid misuse among patients. The development of unit-dose blister packaging has successfully aided the CDC's and FDA's plans to limit the initial prescriptions for acute pain by providing pre-packed doses. Unit-dose packaging is gaining momentum in blister packaging, as it offers advantages, such as decreased dosing intervals for some of the chronic care patients.
  • In early 2019, PCI Pharma Services announced the launch of child-resistant blister packaging. Its investments across US facilities were the result of the new opioid legislation in the United States. The US DEA Schedule I-V controlled substances for both commercial prescription medicines and investigational clinical trials that were being supported by the company. Since then, the company's significant investments have been to expand the existing capacity for blister packaging to meet the stringent requirements of the regulatory authorities. Thus, the company can now produce more than five billion units of blister packs annually.
  • Also, as per Parata Systems, non -adherence to medication, on average, costs USD 300 billion/year in the United States. Pouch packaging has reduced the cost of care and improved patient outcomes. With the growing presence of strip packaging in the market, patient awareness is expected to pressurize pharmacies without proper packaging to be left behind. The company launched Parata PASSTM 36, targeting pharmacies. Parata Systems, being a provider of pharmacy automation systems, including vial -filling, adherence packaging, and workflow and patient experience solutions, launched a pouch packager, named PASSTM 36.

Competitive Landscape

The global adherence packaging market is moderately competitive and consists of a few significant players. Companies like Cardinal Health, Inc., WestRock Company, Omnicell Inc., Parata Systems LLC, and Keystone Folding Box Co., among others, hold a substantial market share in the Adherence Packaging market. The market various is also witnessing multiple product launches and partnerships.

  • February 2020 - Parata Systems launched a new pouch packager, the PASS 36. The Parata PASS 36 with a small footprint and low cost now provides pharmacies ready to begin their adherence packaging program with automation designed to handle smaller volumes while promising the scalability a growing business needs.
  • January 2020 - Omnicell, Inc. showcased the latest advancements to its medication management portfolio at the Arab Health Exhibition and Congress, Dubai. Omnicell's platform of automation solutions supports medication safety on patient wards; provides more efficient medication storage, dispensing, and filling in the hospital pharmacy; and helps improve medication adherence through automated multimed packaging solutions for an outpatient pharmacy, which can result in better patient outcomes.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Supply Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Rise in Need to Minimize Medication Wastage
    • 5.1.2 High Rate of Medication Non-Adherence
  • 5.2 Market Challenges
    • 5.2.1 High Installation and Maintenance Costs of Automated Systems
    • 5.2.2 Lack of Awareness Regarding Medication Adherence Packaging
  • 5.3 Market Opportunties

6 IMPACT OF COVID-19 ON THE PACKAGING INDUSTRY

7 GOVERNMENT REGULATIONS

8 MARKET SEGMENTATION

  • 8.1 By Material
    • 8.1.1 Plastic (PE, PET, PVC, and PP)
    • 8.1.2 Paper and Paperboard
    • 8.1.3 Aluminum
  • 8.2 By Type
    • 8.2.1 Unit-dose Packaging
    • 8.2.2 Multi-dose Packaging
  • 8.3 By Packaging Type
    • 8.3.1 Blisters
    • 8.3.2 Pouches
    • 8.3.3 Other Packaging Types
  • 8.4 By End-User Industry
    • 8.4.1 Pharmacies
    • 8.4.2 Hospitals
    • 8.4.3 Other End-user Industries
  • 8.5 Geography
    • 8.5.1 North America
    • 8.5.2 Europe
    • 8.5.3 Asia Pacific
    • 8.5.4 Latin America
    • 8.5.5 Middle East and Africa

9 COMPETITIVE LANDSCAPE

  • 9.1 Company Profiles
    • 9.1.1 Westrock Company
    • 9.1.2 Keystone Folding Box Co.
    • 9.1.3 Cardinal Health Inc
    • 9.1.4 Omnicell Inc.
    • 9.1.5 Jones Healthcare Group
    • 9.1.6 Drug Package LLC
    • 9.1.7 Parata Systems LLC

10 FUTURE OUTLOOK OF THE MARKET